Carnival deploys two cruise ships to Chinese market
Global travel and leisure company Carnival Corporation has announced a year round operation of its two cruise ships, Carnival Miracle and Carnival Splendor, in the Chinese market.
Carnival Miracle will commence operations in mid-2017 followed by Carnival Splendor in mid-2018.
Both the ships are expected to offer a high-quality vacation experience with a friendly atmosphere.
Carnival will be establishing operations in China in partnership with sister company Costa Asia, which has operated in the Chinese market for the past nine years.
Carnival Cruise Line president Christine Duffy said: "Given the combined experience of Costa Asia, along with other sister companies either already in the market, such as Princess Cruises, or entering the market, such as AIDA, the collective scale of Carnival Corporation's Asia operations is unparalleled and enables us to tap into an immense network of resources and expertise as we launch our China programme."
Specific details on the company's China itineraries will be announced at a later time.
Carnival has recently formed a joint venture with China State Shipbuilding Corporation (CSSC) and China Investment Corporation (CIC) to launch a multi-ship domestic cruise brand in the Chinese market.
Earlier this month, the company had announced the addition of Carnival Cruise Line and AIDA Cruises in the Chinese market in 2017, a part of its strategy to offer multi brands to Chinese travellers, bringing the total number of its brands operating in the country to four, including the existing Costa Cruises and Princess Cruises.
The company also announced in July that the two brands under operations in China, Costa Cruises and Princess Cruises, will continue to expand in 2016 increasing the company's total capacity in China by an additional 58%.
Princess Cruise's latest ship, which is under construction, will also be based in China and is expected to enter the Chinese market in 2017.
Image: Carnival Splendor. Photo: courtesy of Andy Newman / CCL.